Frequently Asked Questions
We treat both malignant and non-malignant blood disorders including leukemia, lymphoma, multiple myeloma, anemia, thalassemia, sickle cell disease, and bleeding disorders.
Bone marrow transplant is a medical procedure that replaces damaged or diseased bone marrow with healthy stem cells to treat blood cancers and genetic disorders.
We perform autologous (self-donor), allogeneic (donor-based), matched sibling/unrelated, and haploidentical bone marrow transplants.
Eligibility is based on disease type, patient health, and donor availability. Our specialists assess each patient through detailed pre-transplant evaluation.
Success rates depend on the condition, transplant type, and patient health. Our outcomes are aligned with international standards.
We use chemotherapy, targeted therapy, immunotherapy, and bone marrow transplant depending on cancer type and stage.
Yes, we offer pediatric hematology and BMT services for thalassemia, sickle cell anemia, and congenital blood disorders.
Yes, we have in-house HLA typing facilities using advanced techniques for precise transplant compatibility matching.
We use HEPA-filtered rooms, strict sterilization, trained nursing teams, and 24/7 monitoring to prevent infections during BMT.
Appointments can be booked online via our website or by calling our hospital directly for a consultation.